MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$227,318K
EPS
-$3.53
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
202,862
General and administrative
41,972
Total operating expenses
244,834
Operating loss
-244,834
Interest expense
7,248
Other income, net
22,372
Loss before income tax
-229,710
Income tax expense
611
Net loss
-230,321
Of which net loss attributable to controlling interests shareholders
-227,318
Basic EPS
-3.53
Diluted EPS
-3.53
Basic Average Shares
64,463,889
Diluted Average Shares
64,463,889
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Of which net lossattributable to controlling...-$227,318K Net loss-$230,321K Loss before incometax-$229,710K Income tax expense$611K Other income, net$22,372K Operating loss-$244,834K Interest expense$7,248K Total operatingexpenses$244,834K Research and development$202,862K General andadministrative$41,972K

MoonLake Immunotherapeutics (MLTX)

MoonLake Immunotherapeutics (MLTX)